Article
Does recombinant human erythropoietin administration in critically ill COVID‐19 patients have miraculous therapeutic effects?
9 Apr 2020
Abstract excerpt
Abstract An 80‐year‐old man with multiple comorbidities presented to the emergency department with tachypnea, tachycardia, fever, and critically low O2 saturation and definitive chest computerized tomography scan findings in favor of COVID‐19 and positive PCR results in 48 hours. He received antiviral treatment plus recombinant human erythropoietin (rhEPO) due to his severe anemia. After 7 days of treatment, he...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
